MassBio® 2019 Annual Meeting, now the State of Possible Conference, Hosts Brightest Minds in Biotech

Mar 04, 2019

Two-day event & celebration draws over 600 attendees to debate the most pressing challenges facing the life sciences industry

What: MassBio’s Annual Meeting, now the State of Possible Conference, is the premier east coast life sciences conference. Drawing over 600 attendees from Massachusetts and beyond, the Conference will feature biotech’s brightest minds as they discuss what’s possible for patients and the industry now that wasn’t five or even 10 years ago. In addition to conference-wide panels with business and science breakout sessions, the Conference will include a series of Possible Talks modeled after TED Talks where experts will give 15-minute mini-keynotes on a variety of topics impacting the life sciences.

And, for the first year ever, the State of Possible Celebration – included with registration and sponsored by Morgan Stanley – will be taking place at the Museum of Science. This one-of-a-kind event will celebrate the people and companies who make Massachusetts the best place in the world for bringing new therapies and cures to patients.

When: March 27, 2019 at 8 am – March 28, 2019 at 3 pm

Where: Conference to take place at the Royal Sonesta, 40 Edwin Land Boulevard, Cambridge MA; evening celebration to take place at the Museum of Science, 1 Science Park, Boston, MA 02114 (transportation will be provided to museum)

Who: With new speakers added each day, the State of Possible Conference will host some of the biggest names in biotech and address pressing industry issues and innovations around drug pricing, precision medicine, neurodegenerative disease, CFIUS & more. A few highlights:

  • Keynote Address from Jeremy Levin, Chairman & CEO, Ovid Therapeutics, Inc.
  • ‘Fireside Chat’ with John Maraganore & Katrine Bosley on RNAi and CRISPR: What Can the Past Teach Us and What Opportunities Await?
  • Future of Human Biology panel discussion with George M. Church Phd, Professor of Genetics, Harvard Medical School, Juan Enriquez, Managing Director, Excel Venture Management & Greg Verdine, President, CEO & CSO, Board Member, LifeMine.
  • A look at the financial outlook for 2019-2020 presented by Bruce Booth, Partner, Atlas Ventures, Barbara Dalton, Managing Director, Pfizer Venture & more.
  • Calum MacRae, Vice Chair for Scientific Innovation, Brigham and Women’s Hospital, Harvard Medical School, will discuss the challenges and opportunities for precision medicine in large population diseases.
  • Awards reception to honor Lita Nelson, Retired Director of the MIT Technology Licensing Office, who will receive the Henri A. Termeer Innovative Leadership Award.

View the full agenda here.

Interested media can register for free by contacting Jennifer Nason.

Morgan Stanley is the premier sponsor of the event. Other sponsors include: Amgen, Cambrex, Bayer, BeiGene, Boston Analytical, Corealis Pharma, Corning, McDermott Will & Emory, PHASTAR, Ropes & Gray, Fisher Scientific, uniQure, WilmerHale, Biogen, KCR, Hogan Lovell’s, Harvard Medical School, Sanofi Genzyme, Parexel, Eloxx and Nikon.

See all MassBio News